Cytokinetics pharmaceuticals stock

WebApr 10, 2024 · The company’s shares closed last Thursday at $78.78. Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to... Web12 hours ago · In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed last Thursday at $35.93, close to its 52-week low of $32.96.

Cytokinetics Muscle Biology Therapies Company

WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. philosophy black friday https://bigwhatever.net

Cytokinetics To Participate In The 22nd Annual Needham Virtual ...

WebJan 11, 2024 · Contact: Cytokinetics MD: 650-624-2929: [email protected]: Locations. Show 105 study locations Sponsors and Collaborators ... Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. Investigators. Layout table for investigator information; Study Director: Cytokinetics MD: Cytokinetics: WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) Cardiovascular and Renal... philosophy berkeley courses

Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Citius ...

Category:Cytokinetics, Incorporated Common Stock (CYTK) - Nasdaq

Tags:Cytokinetics pharmaceuticals stock

Cytokinetics pharmaceuticals stock

Cytokinetics Inc (CYTK) Stock Price Today, News, Quotes, FAQs …

WebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function. WebNov 3, 2024 · Cytokinetics (CYTK) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of a loss of $1.19. This compares to loss of $0.95 per share a year ago.

Cytokinetics pharmaceuticals stock

Did you know?

WebJan 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebMar 27, 2024 · PRESS RELEASES Cytokinetics, Inc. INVESTORS & MEDIA 2024 Press Releases Webcast 22nd Annual Needham Virtual Healthcare Conference Apr 17, 2024 10:00 AM EDT Keyword Search Press Release Archive 1998-2005 Year 2024 Apr 11 2024 5:00 pm EDT Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART

WebMar 7, 2024 · Cytokinetics (Nasdaq:CYTK) earnings and revenue forecasts, price targets, future return on equity. ... President & Director exercised options and sold US$333k worth of stock Aug 04. Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M ... High growth companies in the Pharmaceuticals & Biotech industry. WebNov 8, 2024 · Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional $18.0 million aggregate principal amount of the notes in connection with the offering, solely to cover...

WebApr 9, 2024 · Cytokinetics Trading Up 0.7 %. Cytokinetics stock opened at $36.42 on Friday. The business’s 50 day simple moving average is $39.79 and its 200 day simple moving average is $42.22. WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has …

WebJan 8, 2024 · According to the 10-Q SEC Filing, Cytokinetics had cash, cash equivalents and investments of $668.9 million as of September 30, 2024. A big reason for the cash on hand was because of an offering...

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Investor Overview Stock … t-shirt googleWebMar 31, 2024 · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) SOUTH SAN FRANCISCO, Calif. , April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) … t-shirt golfWebFeb 17, 2024 · In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Cytokinetics, with a price target of $80.00. The company’s shares closed … t shirt gooddaysnighttorunWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision Leadership … t shirt golds gymWebDec 9, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. philosophy black friday 2022WebMar 31, 2024 · Cytokinetics' heart disease drug, aficamten, is a "crown jewel in terms of the pipeline", said Oppenheimer analyst Justin Kim, who expects it could bring more than $1 billion in peak sales from U ... philosophy black friday 2021WebMar 6, 2024 · PRESENTATIONS Cytokinetics, Inc. INVESTORS & MEDIA PRESENTATIONS NASDAQ : CYTK $35.19 +0.98 (+2.86%) Mar 31 2024 4:00 pm EDT Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART SHAREHOLDER TOOLS Print Page Email Alerts IR/Media Contacts t shirt gorillaz homme